The API unit was established in 2008 with an oncology block which is currently under expansion and will reach a capacity of 24 million tonne/year. From January 2012, a non-oncology section built on ~ 50.000 sqm will become fully functional.

The API manufacturing facilities are fully compliant with EU, FDA and other authorities and has a number of EU and US DMFs and CEP products.

Research and Development is an integral part of the API unit and its dedicated scientists support both new product development as well as process optimisation.